Welcome to the latest edition of the MassDevice.com’s D+Vice Talk, our new webcast, in which we review medical device stories from the last week.
In this episode we start with updates from Capitol Hill, review highlights from the American College of Cardiology conference, consider the mixed FDA reports for Abbott’s MitraClip heart implant and debate Dr. Robert Hauser’s controversial proposal to overhaul the FDA.
Find all of today’s referenced stories here:
- Medical device tax: New repeal proposal recoups revenue from oil companies
- FDA refutes iPhone medtech tax rumors
- Hamburg: Federal sequester could sour future FDA negotiations with device and drug makers
- From the American College of Cardiology conference
- Boston Scientific apologizes for embargo breach that got its Watchman trial pulled from conference
- TAVI: Sapien going strong at 3 years, but leak risk remains "overwhelmingly" higher
- Early results "encouraging" for Edwards’ redesigned Sapien XT valve
- Transcatheter mitral valves are going to the dogs
- FDA panel splits on Abbott’s MitraClip heart implant
- Hauser’s FDA Rx: The FDA needs an NTSB
- Making the patient connection: A conversation with NBA legend Bill Walton
- The 6 lines of code that could bring down a hospital
